Results 51 to 60 of about 32,840 (255)
CLINICAL CASE OF RARE TYPE V OSTEOGENESIS IMPERFECTA
Osteogenesis imperfecta, also known as the brittle bone disease, is a clinically heterogenic hereditary connective tissue disease characterized by brittle bones and high risk of skeletal bone fractures.
G. T. Yakhyayeva+8 more
doaj +1 more source
Pattern of distribution of patients presenting with osteogenesis imperfecta at AIC cure Children's International Hospital, Kijabe [PDF]
Background: Osteogenesis imperfecta is one of the common diseases encountered at AIC CURE Children’s International Hospital (Cure Hospital Kenya). Osteogenesis imperfecta is a rare condition constituting 2% of all cases seen at the hospital.
Macharia, JT, Mwangi, GC
core +2 more sources
The IMPACT Survey: the economic impact of osteogenesis imperfecta in adults
Background The IMPACT survey aimed to elucidate the humanistic, clinical and economic burden of osteogenesis imperfecta (OI) on individuals with OI, their families, caregivers and wider society.
Tracy Hart+8 more
doaj +1 more source
Gagal Jantung Kongestif Et Causa Osteogenesis Imperfecta [PDF]
Latar Belakang. Osteogenesis imperfecta adalah kelainan jaringan ikat dan tulang yang bersifat herediter yang mengakibatkan kerapuhan tulang, kelemahan persendian dan kerapuhan pembuluh darah.
Dzikrifishofa, M. (Muhammad)
core
Viridicatol from the Deep‐Sea‐Derived Fungus Alleviates Bone Loss by Targeting the Wnt/SHN3 Pathway
Viridicatol (VDC), isolated from the deep‐sea‐derived fungus, enhances osteogenesis in vitro and in vivo by targeting Wnt/SHN3 signaling pathway. It can be delivered via engineered nanovesicles to mitigate bone loss of osteoporosis, fracture repair, and osteogenesis imperfecta.
Chun‐Lan Xie+10 more
wiley +1 more source
Personalized Bonding Approach for Full‐Mouth Adhesive Rehabilitation in Dentinogenesis Imperfecta
ABSTRACT Dentinogenesis imperfecta is a rare genetic disorder impacting dentin structure, with an incidence of 1 in 6000 to 1 in 8000 individuals. This condition alters the tooth's color and structure, affecting patients aesthetically, functionally, and socially.
Cyprien Clark+2 more
wiley +1 more source
Regulatory marketing authorisation is not enough to ensure patient access to new medicinal products. Health Technology Assessment bodies may require data on effectiveness, relative effectiveness, and cost-effectiveness.
L. Sangiorgi+6 more
doaj +1 more source
Otopathology in Osteogenesis Imperfecta [PDF]
Osteogenesis Imperfecta (OI) is a genetic disorder of connective tissue matrix. OI is caused by mutations that affect type I collagen. The hearing loss in OI is characterized by onset in early adulthood and can be conductive, sensorineural, or mixed.To describe the temporal bone histopathology in 9 individuals with OI.Four adult, 1 pediatric, and 4 ...
Andrew A. McCall+3 more
openaire +2 more sources
The article presents the modern views of clinicians and geneticists on one of the most severe genetic disorders of skeletal and connective tissues - osteogenesis imperfecta. The review provided the literature data that showed the incidence rates, genetic
L. Ya. Klimov+10 more
doaj +1 more source
Macroscopic Anisotropic Bone Material Properties in Children with Severe \u3cem\u3eOsteogenesis imperfecta\u3c/em\u3e [PDF]
Children with severe osteogenesis imperfecta(OI) typically experience numerous fractures and progressive skeletal deformities over their lifetime. Recent studies proposed finite element models to assess fracture risk and guide clinicians in determining ...
Albert, Carolyne+4 more
core +1 more source